Related Articles
Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells
Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P‑glycoprotein and MRPs expression Retraction in /10.3892/ol.2024.14568
Effects of KAI gene expression on ferroptosis in pancreatic cancer cells
The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine
Akt inhibitor MK‑2206 reduces pancreatic cancer cell viability and increases the efficacy of gemcitabine